| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.0096 | 1 |